Antipsychotic Drugs Market Insights: Revenue Expected to Surpass $30.39 Billion by 2029

Uncover key drivers, emerging technologies, and competitive movements shaping the antipsychotic drugs market from 2025–2034 with trusted insights from The Business Research Company

What Is The Current Size And Expected Growth Outlook For The Antipsychotic Drugs Market?

The antipsychotic drugs market has experienced robust growth in recent years. It is projected to expand from $19.5 billion in 2024 to $21.25 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.0%. The historical growth of this market can be attributed to the increasing prevalence of mental health disorders, the development of second-generation antipsychotics, an expanding geriatric population, enhancements in healthcare infrastructure, and substantial investment in research and development.

The antipsychotic drugs market is projected to experience substantial expansion in the coming years. It is forecast to reach $30.39 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.4%. This anticipated growth during the forecast period is driven by several factors, including the rising occurrence of schizophrenia and bipolar disorder, favorable government policies and financial support, an increasing need for personalized medicine, efforts to minimize side effects, and the expansion of mental health advocacy and support organizations. Key trends anticipated for this period encompass the incorporation of digital health tools for monitoring, the creation of new mechanisms of action, a heightened emphasis on combination therapies, the use of pharmacogenomics for customized treatments, and a focus on drug development centered around patients.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18780&type=smp

Which Growth Drivers Are Propelling The Antipsychotic Drugs Market?

The escalating prevalence of mental disorders is projected to advance the antipsychotic drug market in the future. These conditions, also referred to as mental illnesses, are health issues that affect an individual’s thoughts, conduct, emotional state, and overall mental well-being. Factors such as stress levels, societal pressures, genetic predisposition, biochemical imbalance, neurodevelopmental issues, and physical health conditions can influence instances of mental disorders. Antipsychotic medications manage mental disorders by modulating the activity of neurotransmitters, chiefly dopamine and serotonin, thereby diminishing psychotic symptoms, stabilizing mood, and enhancing cognitive and emotional functions. For example, a survey by the Substance Abuse and Mental Health Services Administration (SAMHSA), a US-based public health agency, indicated that in November 2023, about 6% of adults aged 18 or older, totaling 15.4 million individuals, reported experiencing serious mental illness (SMI). Additionally, the Australian Institute of Health and Welfare, an Australia-based government body, stated in September 2024 that the population living with dementia in Australia is anticipated to more than double from approximately 411,100 in 2023 to 849,300 by 2058. This rise is expected to impact roughly 315,500 men and 533,800 women. Consequently, the increasing occurrence of mental disorders is fueling the antipsychotic drug market.

Which Segmentation Factors Are Most Significant In The Antipsychotic Drugs Market Analysis?

The antipsychotic drugs market covered in this report is segmented –

1) By Therapeutic Class: First Generation, Second Generation, Third Generation

2) By Disease: Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Other Diseases

3) By Distribution Channel: Hospital Pharmacies, Drug Stores, Online Pharmacies

Subsegments:

1) By First Generation: Typical Antipsychotics, Phenothiazines, Butyrophenones, Thioxanthenes, Dibenzoxazepines

2) By Second Generation: Atypical Antipsychotics, Clozapine, Olanzapine, Risperidone, Quetiapine, Aripiprazole, Paliperidone, Lurasidone

3) By Third Generation: Partial Dopamine Agonists, Aripiprazole, Brexpiprazole, Cariprazine

What New Opportunities Are Emerging From Trends In The Antipsychotic Drugs Market?

Major companies operating in the antipsychotic drug market are focused on developing advanced medical products, such as subcutaneous atypical antipsychotic injections, to offer improved patient compliance and enhanced efficacy compared to traditional oral medications. Subcutaneous atypical antipsychotic injections are psychiatric drugs that are given under the skin to treat mental illnesses, maintain stable blood levels, and improve symptom control. For instance, in April 2023, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical company, and MedinCell SA, a France-based manufacturer of biological products and pharmaceutical preparations, launched U.S. Food and Drug Administration (FDA)-approved UZEDY. It is an extended-release injectable formulation of risperidone designed as a long-acting subcutaneous injection that offers flexible dosing intervals of one or two months. UZEDY utilizes MedinCell’s proprietary SteadyTeq technology, which ensures a steady release of the medication, reaching therapeutic levels within 6–24 hours of administration. In clinical trials, UZEDY demonstrated up to an 80% reduction in the risk of schizophrenia relapse compared to placebo. It is intended to address adherence issues commonly associated with oral antipsychotics, which often lead to relapse.

Who Are The Most Influential Companies In The Antipsychotic Drugs Market?

Major companies operating in the antipsychotic drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Merck And Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Aurobindo Pharma Ltd., Cipla Ltd., H. Lundbeck A/S, Dr. Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., Apotex Inc., Lupin Limited, Glenmark Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Alkermes plc

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/antipsychotic-drugs-global-market-report

Which Region Holds The Largest Share In The Antipsychotic Drugs Market Today?

North America was the largest region in the antipsychotic drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antipsychotic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=18780&type=smp

Browse Through More Reports Similar to the Global Antipsychotic Drugs Market 2025, By The Business Research Company

Acne Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report

Drugs For Immunotherapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drugs-for-immunotherapy-global-market-report

Skin Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/skin-cancer-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795